Amoéba
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Materials
- Industry:
- Chemicals
Description
Created in July 2010, Amoéba is an innovative company whose initial objective was to develop a patent from the University of Lyon. This patent is based on a unique micro-organism, the amoeba Willaertia magna C2c Maky, which is able to fight against the proliferation of legionella. Amoéba has been able to develop its scientific, industrial and commercial expertise around the amoeba. We are now able to offer technological solutions and products for different applications and industries. Amoeba has developed two technologies. The first one is used for the treatment of water, surfaces and chronic wounds and uses for that the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky. The second technology is dedicated to agriculture and more precisely to biocontrol for the treatment of phytopathogenic microorganisms using the lysed (non-living) form of this same amoeba.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-17 18:00 |
Regulatory News Service
Amoéba takes another decisive step forward with the final approval of its bioco…
|
English | 391.5 KB | |
| 2025-06-17 18:00 |
Regulatory News Service
Amoéba franchit une nouvelle étape décisive avec l'approbation définitive de sa…
|
French | 387.4 KB | |
| 2025-06-03 17:45 |
Regulatory News Service
Koppert et Amoéba signent un accord de distribution majeur pour une solution bi…
|
French | 191.6 KB | |
| 2025-06-03 17:45 |
Regulatory News Service
Koppert and Amoéba sign major distribution agreement for innovative biofungicid…
|
English | 170.4 KB | |
| 2025-05-22 18:00 |
General Meeting Notice
Amoéba: Ordinary and Extraordinary General Meeting of 26 June 2025
|
English | 332.5 KB | |
| 2025-05-22 18:00 |
General Meeting Notice
Amoéba : Assemblée Générale Ordinaire et Extraordinaire du 26 juin 2025
|
French | 331.8 KB | |
| 2025-05-21 18:00 |
Regulatory News Service
A new milestone towards the market launch of AXPERA: EU Member States unanimous…
|
English | 375.5 KB | |
| 2025-05-21 18:00 |
Regulatory News Service
Nouvelle étape franchie vers la mise sur le marché d'AXPERA : vote à l'unanimit…
|
French | 372.5 KB | |
| 2025-05-20 19:00 |
Board/Management Change
Amoéba announces the nomination of Charlotte Franceries, a leading figure in th…
|
English | 339.5 KB | |
| 2025-05-20 19:00 |
Board/Management Change
Amoéba annonce l'arrivée au sein de son Conseil d'administration de Charlotte F…
|
French | 352.3 KB | |
| 2025-05-12 18:00 |
Regulatory News Service
Amoéba et Koppert continuent de préparer le lancement commercial d'AXPERA, le p…
|
French | 325.9 KB | |
| 2025-05-12 18:00 |
Regulatory News Service
Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the bio…
|
English | 328.8 KB | |
| 2025-05-06 08:00 |
Regulatory News Service
Amoéba obtient une dérogation exceptionnelle aux Pays-Bas pour son produit de b…
|
French | 4.0 MB | |
| 2025-05-06 08:00 |
Regulatory News Service
Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol p…
|
English | 4.0 MB | |
| 2025-04-22 18:00 |
Regulatory News Service
New strategic milestone for Amoéba: Axpéra biocontrol product receives emergenc…
|
English | 399.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-08 | N/A | Other | Buy | 9,260 | 4,900.39 EUR |
| 2024-08-07 | N/A | Other | Buy | 17,556 | 8,943.03 EUR |
| 2024-08-06 | N/A | Other | Buy | 4,874 | 2,252.76 EUR |
| 2024-08-05 | N/A | Other | Buy | 16,517 | 7,295.56 EUR |
| 2024-07-31 | N/A | Other | Buy | 58,309 | 26,868.79 EUR |
| 2024-07-30 | N/A | Other | Buy | 6,197 | 2,701.27 EUR |
| 2024-07-29 | N/A | Other | Buy | 7,404 | 3,253.32 EUR |
| 2024-07-18 | N/A | Other | Buy | 13,437 | 6,167.58 EUR |
| 2024-07-17 | N/A | Other | Buy | 200 | 92.70 EUR |
| 2024-07-16 | N/A | Other | Buy | 3,565 | 1,620.29 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Afyren | France | ALAFY | |
|
Air Liquide | France | AI | |
|
A.J. Green Shell Plc | Cyprus | ROFOL | |
|
Akzo Nobel N.V. | Netherlands (Kingdom of the) | AKZA | |
|
AlzChem Group AG | Germany | ACT | |
|
Avantium N.V. | Netherlands (Kingdom of the) | AVTX | |
|
aXichem AB | Sweden | AXIC | |
|
BAHADIR KİMYA SANAYİ VE TİCARET A.Ş. | Türkiye | BAHKM | |
|
Baikowski | France | ALBKK | |
|
BAYRAK EBT TABAN SANAYİ VE TİCARET A.Ş. | Türkiye | BAYRK |